Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 05/21 10:24:24 am
24050 ILa   +2.38%
05/21DJLaw Firm Advising Teva Dismisses Mylan Objections
05/21DJLaw Firm Advising Teva on Bid Dismisses Mylan's Objections to Its..
05/19 TEVA PHARMACEUT : ex-dividend day for interim dividend
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

07/01/2013 | 07:27am US/Eastern
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
React to this article
Latest news on TEVA PHARMACEUTICAL INDUST
05/21DJLaw Firm Advising Teva Dismisses Mylan Objections
05/21DJLaw Firm Advising Teva on Bid Dismisses Mylan's Objections to Its Involvement
05/20 TEVA PHARMACEUTICAL : Presents Further Data from Phase IIb with TEV-48125 in Chr..
05/19 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : ex-dividend day for interim dividend
05/18 Endo pushes further into generics with $8 billion Par Pharma buy
05/17 NOBLE ENERGY : BRIEF: George Soros exits Teva
05/15 TEVA PHARMACEUTICAL : An Application for the Trademark "BENDEKA" Has Been Filed ..
05/15 TEVA PHARMACEUTICAL : Trademark Application for "BENEETAH" Filed by Teva Pharmac..
05/15 TEVA PHARMACEUTICAL : Provides Additional Detail on Proposed Acquisition of Myla..
05/15 TEVA PHARMACEUTICAL : Reports First Quarter 2015 Results
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
More Financials